Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Drug Collaborations - Related Parties (Details Narative)

v3.19.1
3. Significant Strategic Drug Collaborations - Related Parties (Details Narative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Drug Development Collaborations [Member]    
Revenues $ 0 $ 0